Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.52
-4.74 (-1.81%)
AAPL  315.20
+8.89 (2.90%)
AMD  521.54
+11.41 (2.24%)
BAC  52.48
+0.97 (1.88%)
GOOG  358.39
-14.19 (-3.81%)
META  597.63
-2.84 (-0.47%)
MSFT  441.31
-19.21 (-4.17%)
NVDA  222.82
-1.54 (-0.69%)
ORCL  244.58
-3.57 (-1.44%)
TSLA  423.74
+7.86 (1.89%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.